Join Associate Director Suzanne Schwartz from the Food and Drug Administration and Digital Shadows for an informative session on best practices for eliminating risks in an evolving regulatory environment and the role of advanced threat intelligence in preventing devastating cyber‐attacks.
By attending this session, you’ll takeaway:
- How third parties and suppliers put organizations at risk
- Visibility into the medical device threat landscape and latest recalls
- Mitigating third party risk and infrastructure exposure to ensure regulatory compliance
